Always check your plan's drug list at uhc.com or by calling member services
Key Industry Highlights: Dominant Segment : Ozempic leads the GLP-1 receptor agonist market in 2025 , with a 32.1% share , driven by its strong clinical efficacy in HbA1c reduction, proven cardiovascular benefits, and superior weight-loss outcomes
Consent for publication All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published
A Fella provider may prescribe a compounded medication if they determine its an appropriate part of your treatment plan
Does Wegovy have any known side effects
LC-MS/MS is the gold-standard analytical technique for sequencing GLP-1 and its analogs